Drugs that contain Topotecan Hydrochloride
1. Hycamtin patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5674872 | SANDOZ | Treatment of ovarian cancer |
Oct, 2014
(9 years ago) | |
|
US5674872 (Pediatric) | SANDOZ | Treatment of ovarian cancer |
Apr, 2015
(9 years ago) | |
| US8158645 | SANDOZ | Compound, corresponding compositions, preparation and/or treatment methods |
Dec, 2024
(7 months from now) | |
Market Authorisation Date: 28 May, 1996
Treatment: Treatment of metastatic carcinoma of the ovary after failure of initial or subsequent chemotherapy
Dosage: INJECTABLE;INJECTION; CAPSULE;ORAL
More Information on Dosage
HYCAMTIN family patents
